Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124299) titled 'Association of Leflunomide with Early-Stage Atherosclerotic Lesions in Rheumatoid Arthritis Patients' on May 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai General Hospital
Condition:
Subclinical Atherosclerosis
Intervention:
Exposed group (leflunomide)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-16
Target Sample Size: Exposed group (leflunomide); Control group (without leflunomide):120;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=310259
Published by HT Digital Content Ser...